Kester Capital bulks out deals team to speed investment of newly-raised sophomore fund
Kester Capital has bulked out its dealmaking team by bringing in three new associates.
Kester Capital has bulked out its dealmaking team by bringing in three new associates.
Drug discovery software provider Optibrium has been bought by Kester Capital in the firm's third deal since closing its £90m sophomore fund.
Kester Capital has hit the £90m hard cap for the final close of its oversubscribed sophomore fund.
